KELLEHER FINANCIAL ADVISORS
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1507971
NEW YORK, NY
Position in VRTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$44,654
-$682 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KELLEHER FINANCIAL ADVISORS holds $324,622 across 5 Biotechnology names. VRTX ranks #3 (13.8% of the industry book) .
All Filings in VRTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,654 | 100 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $45,336 | 100 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $39,164 | 100 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||